Page last updated: 2024-08-23

paroxetine and Myelodysplastic Syndromes

paroxetine has been researched along with Myelodysplastic Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiu, YL; Chu, TS; Chuang, YF; Hwang, TJ	1

Other Studies

1 other study(ies) available for paroxetine and Myelodysplastic Syndromes

Article	Year
Delirium and multiple electrolyte abnormalities associated with high dose paroxetine exposure. Psychiatry and clinical neurosciences, 2006, Volume: 60, Issue:5 Topics: Antidepressive Agents, Second-Generation; Delirium; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Myelodysplastic Syndromes; Paroxetine; Water-Electrolyte Imbalance	2006

Article

Year

Delirium and multiple electrolyte abnormalities associated with high dose paroxetine exposure.

Psychiatry and clinical neurosciences, 2006, Volume: 60, Issue:5

Topics: Antidepressive Agents, Second-Generation; Delirium; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Myelodysplastic Syndromes; Paroxetine; Water-Electrolyte Imbalance

2006